Home › Funds › MIZUHO MARKETS AMERICAS LLC › HALO

MIZUHO MARKETS AMERICAS LLC position in HALO

HALOZYME THERAPEUTICS INC · Health Care

MIZUHO MARKETS AMERICAS LLC reported holding 445,808 shares of HALO (HALOZYME THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$49.2M, representing 0.92% of its reported portfolio and ranking #28 among its reported holdings. MIZUHO MARKETS AMERICAS LLC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)445.81K sh
Reported value held$49.22M
Portfolio Weight0.92%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MIZUHO MARKETS AMERICAS LLC's HALO position evolved

MIZUHO MARKETS AMERICAS LLC first disclosed a stake in HALO in Q3 2023 at 402,663 shares (US$15.4M). The position peaked in Q1 2026 at 1,323,544 shares, worth US$85.5M. Across 13 filings, MIZUHO MARKETS AMERICAS LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 445,808 shares valued at US$49.2M — an increase of 52,727 shares quarter over quarter.. Notable position changes include a 271% increase in Q4 2025 (shares fell 4% over the following quarter), a 70% trim in Q2 2026 (shares rose 41% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 402.66K $15.38M New
Q4 2023 446.66K $16.51M Add
Q1 2024 456.64K $18.58M Add
Q2 2024 438.11K $22.94M Reduce
Q3 2024 375.45K $21.49M Reduce
Q4 2024 467.28K $22.34M Add
Q1 2025 374.17K $23.88M Reduce
Q2 2025 397.33K $20.67M Add
Q3 2025 342.15K $25.09M Reduce
Q4 2025 1.27M $85.38M Add
Q1 2026 1.32M $85.54M Add
Q2 2026 393.08K $30.77M Reduce
Q3 2026 445.81K $49.22M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About HALO and 13F data

HALO (HALOZYME THERAPEUTICS INC) is a Health Care company. 45 other funds we track also report a position in HALO — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$251.9M), SNYDER CAPITAL MANAGEMENT L P (US$187.5M), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (US$178.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding HALO

All HALO fund holders →

FAQ

How long has MIZUHO MARKETS AMERICAS LLC held HALO?

MIZUHO MARKETS AMERICAS LLC has disclosed HALO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MIZUHO MARKETS AMERICAS LLC's current position in HALO?

As of Q3 2026, MIZUHO MARKETS AMERICAS LLC holds 445.81K shares of HALO (HALOZYME THERAPEUTICS INC), valued at $49.22M, representing 0.92% of its reported portfolio and ranking #28.

Has MIZUHO MARKETS AMERICAS LLC been buying or selling HALO?

In the latest 13F filing (Q3 2026), MIZUHO MARKETS AMERICAS LLC increased its position in HALO. The position peaked in Q1 2026 at 1.32M shares.

Which other funds hold HALO?

Other major institutional holders of HALO include CONGRESS ASSET MANAGEMENT CO, SNYDER CAPITAL MANAGEMENT L P, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.